Helpdesk

Sales contact

Home > Immuno-Inflammation

Immuno-Inflammation

Case study

Immunology Case Study

Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study duration can be very long whilst patients are in pain....

Article

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in rheumatoid arthritis clinical research

Immuno-Inflammation

Rheumatoid Arthritis (RA) is a common, chronic disease that causes inflammation and often presents with pain in the joints. Untreated,...

Article

Implementing electronic Patient Reported Outcomes (ePROs) in Arthritis Clinical Research: Importance, benefits, and management for incorporating ePROs

Immuno-Inflammation

Arthritis is a general term categorized by acute or chronic inflammation of the joints. Arthritis may cause a variety of...

Subscribe to our newsletter

BYOD on the rise

Strategies to promote BYOD adoption by clinical study sites

How Kayentis reduces the CO2 emissions of your eCOA projects...

Empowering patients through data: a collaborative vision of clinical data...

If Patients Want A Better Quality Of Life, Why Isn’t...

Strategies to overcome clinical trials complexities

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA